Vincerx Pharma, Inc. (VINC)
OTCMKTS · Delayed Price · Currency is USD
0.0051
-0.0002 (-3.77%)
At close: Nov 7, 2025
Vincerx Pharma Market Cap
Vincerx Pharma has a market cap or net worth of $26.7 thousand as of November 7, 2025. Its market cap has decreased by -99.77% in one year.
Market Cap
26.70K
Enterprise Value
-4.41M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since May 27, 2020, Vincerx Pharma's market cap has decreased from 22.32M to 26.70K, a decrease of -99.88%. That is a compound annual growth rate of -70.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 7, 2025 | 26.70K | -99.70% |
| Dec 31, 2024 | 8.84M | -64.95% |
| Dec 29, 2023 | 25.23M | 16.73% |
| Dec 30, 2022 | 21.61M | -89.91% |
| Dec 31, 2021 | 214.20M | -26.75% |
| Dec 31, 2020 | 292.41M | 1,210.19% |
| May 27, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 849.15M |
| Elite Pharmaceuticals | 645.15M |
| Glass House Brands | 595.49M |
| Northwest Biotherapeutics | 360.12M |
| American Oncology Network | 326.52M |
| Nika Pharmaceuticals | 311.89M |
| CytoDyn | 308.64M |
| Silence Therapeutics | 304.66M |